ILK-IN-3: A Potent Integrin-Linked Kinase Inhibitor for Cancer Research and Development
Discover the key properties and research applications of ILK-IN-3, a selective integrin-linked kinase inhibitor with significant antitumor potential. Learn why this compound is vital for advancing cancer research and drug discovery.
Get a Quote & SampleProduct Core Value
ILK-IN-3
ILK-IN-3 is a crucial chemical entity for researchers focused on developing novel cancer therapies. As a leading supplier in China, we provide high-quality ILK-IN-3 to meet the stringent demands of scientific investigation. This compound is instrumental in exploring the intricacies of the integrin-linked kinase pathway, a key target in oncology.
- Understand the mechanisms of action of integrin-linked kinase inhibitors through rigorous research and development with ILK-IN-3.
- Achieve reliable and reproducible results in your cancer research with our high-purity pharmaceutical intermediate.
- Advance your drug discovery pipeline by leveraging the antitumor activity demonstrated by ILK-IN-3 in preclinical studies.
- Source critical research chemicals efficiently from a trusted manufacturer in China committed to quality and innovation.
Key Advantages
Potent Inhibition of ILK
ILK-IN-3 selectively inhibits Integrin-Linked Kinase, making it an invaluable tool for studying the role of ILK in cellular processes relevant to cancer, such as cell growth, migration, and survival. This targeted approach helps in understanding complex cancer biology.
Demonstrated Antitumor Activity
With its proven antitumor activity, ILK-IN-3 serves as a promising candidate for combination therapies in cancer treatment. Its efficacy in preclinical models underscores its potential to enhance existing treatment strategies.
High Purity and Quality
We ensure that ILK-IN-3 is supplied with high purity levels, meeting the critical requirements for pharmaceutical intermediates. This commitment to quality guarantees the reliability of experimental outcomes for researchers worldwide.
Key Applications
Cancer Research
ILK-IN-3 is essential for investigating the molecular mechanisms of cancer and developing new therapeutic strategies. Researchers use this compound to study the ILK signaling pathway's role in tumor progression and metastasis, contributing to a deeper understanding of cancer biology.
Drug Discovery
As a selective ILK inhibitor, ILK-IN-3 is a valuable tool in the drug discovery process. It aids in the identification and optimization of novel anticancer agents, particularly those targeting the ILK pathway, a critical player in various malignancies.
Pharmaceutical Intermediates
With its precise chemical structure and high purity, ILK-IN-3 serves as a key pharmaceutical intermediate for synthesizing more complex drug candidates. Its reliable supply from China supports the global pharmaceutical research and manufacturing sector.
Oncology Studies
The compound's direct relevance to oncology makes it a critical reagent for studying cellular responses to ILK inhibition. It allows scientists to explore mechanisms of drug resistance and identify potential biomarkers for targeted cancer therapies.